KELSEY PEARSON: Open Payments
NPI 1619673951 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,768 in 72 payments from 15 companies in 2025. Trend: 2023 $772 · 2024 $1,844 · 2025 $1,768
Food & beverage: $1,768
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $297 |
| LEO Pharma Inc. | 12 | $232 |
| Organon LLC | 8 | $220 |
| Amgen Inc. | 6 | $171 |
| Arcutis Biotherapeutics, Inc. | 12 | $168 |
| ABBVIE INC. | 7 | $139 |
| Janssen Biotech, Inc. | 2 | $121 |
| Lilly USA, LLC | 2 | $113 |
| UCB, Inc. | 3 | $109 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
Products named: ADBRY, VTAMA, OTEZLA, Zoryve, RINVOQ, COSENTYX, TREMFYA, EBGLYSS.
Industry payments across AL — which companies pay providers there.
